Dermatitis, Eczematous Recruiting Phase 3 Trials for Abrocitinib (DB14973)

Also known as: Eczema / Eczematous dermatitis / Eczema NOS / Eczematous rash / Dermatitis eczematoid

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs